SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
RION Announces Initiation of Phase 2A Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers
FDA Clears Magstim Transcranial Magnetic Stimulation System  Horizon 3.0 with StimGuide Pro
Full Spectrum Software Marked Second Consecutive Year of 20 Percent Revenue Growth